Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001513162-15-000596

Vice President-Finance & CFO sold 3,500 shares at an average $3.78 ($13,234)

  • Vice President-Finance & CFO acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HERMS HENRY P · Vice President-Finance & CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2015-10-27 Exercise or conversion : show line 1 in the form +4,000 $2.58 $10,320 26,125 D
2015-10-27 Sale : show line 2 in the form −1,000 $3.79 $3,790 25,125 D
2015-10-28 Sale : show line 3 in the form −1,700 $3.80 $6,460 23,425 D
2015-10-29 Sale : show line 4 in the form −800 $3.73 $2,984 22,625 D
Open-market sales · 3,500 sh · avg $3.78 · $13,234

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-27 Exercise or conversion : show line 5 in the form Employee Stock Option −4,000 0 D
Loading xslF345X03/primary_doc.xml…